These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy. Cerón I; Muñoz P; Marín M; Segado A; Roda J; Valerio M; Bouza E; J Antimicrob Chemother; 2014 Jun; 69(6):1669-74. PubMed ID: 24532682 [TBL] [Abstract][Full Text] [Related]
4. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM; Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215 [TBL] [Abstract][Full Text] [Related]
5. Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis. Briggs S; Broom M; Duffy E; Everts R; Everts G; Lowe B; McBride S; Bhally H J Antimicrob Chemother; 2021 Jul; 76(8):2168-2171. PubMed ID: 33975351 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596 [TBL] [Abstract][Full Text] [Related]
7. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates. Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [TBL] [Abstract][Full Text] [Related]
10. Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs? Herrera-Hidalgo L; de Alarcón A; López-Cortes LE; Luque-Márquez R; López-Cortes LF; Gutiérrez-Valencia A; Gil-Navarro MV Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046488 [TBL] [Abstract][Full Text] [Related]
11. Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review. Peterson SC; Lau TTY; Ensom MHH Ann Pharmacother; 2017 Jun; 51(6):496-503. PubMed ID: 28166656 [TBL] [Abstract][Full Text] [Related]
12. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. Mirna M; Topf A; Schmutzler L; Hoppe UC; Lichtenauer M Clin Res Cardiol; 2022 Oct; 111(10):1077-1086. PubMed ID: 34751788 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis. Freeman L; Milkovits A; McDaniel L; Everson N Int J Antimicrob Agents; 2022 Mar; 59(3):106522. PubMed ID: 35038556 [TBL] [Abstract][Full Text] [Related]
14. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study. Ramos-Martínez A; Pericàs JM; Fernández-Cruz A; Muñoz P; Valerio M; Kestler M; Montejo M; Fariñas MC; Sousa D; Domínguez F; Ojeda-Burgos G; Plata A; Vidal L; Miró JM; PLoS One; 2020; 15(8):e0237011. PubMed ID: 32745091 [TBL] [Abstract][Full Text] [Related]
16. Ampicillin-Ceftriaxone vs Ampicillin-Gentamicin for Definitive Therapy of Shah NH; Shutt KA; Doi Y Open Forum Infect Dis; 2021 Apr; 8(4):ofab102. PubMed ID: 34805443 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Synergism of Penicillin and Ceftriaxone against Thieme L; Briggs S; Duffy E; Makarewicz O; Pletz MW Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683470 [No Abstract] [Full Text] [Related]
18. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis. Euba G; Lora-Tamayo J; Murillo O; Pedrero S; Cabo J; Verdaguer R; Ariza J Antimicrob Agents Chemother; 2009 Oct; 53(10):4305-10. PubMed ID: 19667290 [TBL] [Abstract][Full Text] [Related]
19. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394 [TBL] [Abstract][Full Text] [Related]
20. Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre. Villamarín M; Fernández-Hidalgo N; Viñado B; González-López JJ; Rello P; Escolà-Verg L J Antimicrob Chemother; 2024 Aug; ():. PubMed ID: 39158195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]